GL1X · GenesisL1 explorer

MolNFT v1 · #103173 · protein

Crystal structure of M. tuberculosis DPRE1 in complex with the non- covalent inhibitor TY36C

4P8L · Probable decaprenylphosphoryl-beta-D-ribose oxidase: “Crystal structure of M. tuberculosis DPRE1 in complex with the non- covalent inhibitor TY36C”. X-ray diffraction, 2 ligands (FAD, 36C), 5 pockets (best druggability 0.82). MolNFT…

PDB
4P8L
Type
protein
Length
876 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable decaprenylphosphoryl-beta-D-ribose oxidase
EC
1.-.-.-
UniProt
P72056
Ligands
FAD, 36C
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable decaprenylphosphoryl-beta-D-ribose oxidase (EC 1.-.-.-)protein45731% helix, 24% strandP72056
BProbable decaprenylphosphoryl-beta-D-ribose oxidase (EC 1.-.-.-)protein41930% helix, 26% strandP72056

Ligands and binding sites

  • FAD · Flavin-adenine dinucleotide · ligand · 2 copies · chains A, B
  • 36C · 3-[(4-fluorobenzyl)amino]-6-(trifluoromethyl)quinoxaline-2-carboxylic acid · ligand · 2 copies · chains A, B
  • IMD · Imidazole · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111780.820.83110FAD, 36C
25590.770.8463FAD, 36C
36630.680.7765empty
4890.320.7317empty
5650.310.7517empty

Interfaces

1 interface between chains.

  • A–B · 503 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4P8L · Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.